Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

Add To Watchlist

Bullboard (NDAQ:LEXX)

View:

Post by lscfaon Nov 29, 2022 1:28pm

fins on sedar

Why doesn't co. announce results?

164

(0)
•••

Post by PressReleaseon Nov 21, 2022 9:21am

New Press Release - Lexaria Bioscience Turns Focus to Dementia and Diabetes with New Studies

New York, New York--(Newsfile Corp. - November 21, 2022) - PCG Digital -- Lexaria Bioscience (NASDAQ: LEXX) is investigating the potential therapeutic utility of its proprietary DehydraTECHTM-CBD against dementia and diabetes, two of the world's biggest public health crises. Lexaria...read article.

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

posted Nov 14, 2024 9:00am by NurExone Biologic Inc.

“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more

Post by WakeUPPon Nov 19, 2022 3:25pm

hey dehydratech

IF you are still around WATCH OUT MULTIPLE ACCOUNTS The 'Multiple Accounts' policy is new and will cover users that are attempting to sign up and use multiple accounts on ...more

132

Post by WakeUPPon Nov 15, 2022 2:13pm

dehydraetech

last posted JULY 23 after pumping away all day, every day what id and stock are you on now?????? RiP "dehydratech", i know you will pump on on a gazillion new ids on a different ...more

133

Comment by WakeUPPon Oct 31, 2022 1:46pm

RE:hey dehydratech

And that incldes agstockpickerPUMPER who is down to predicting stocks UNDER .10 cause tha tis all the money he has left to buy a bit of them then PUMP to TRY and get some of his money back ...more

111

Discussion

Post by WakeUPPon Oct 28, 2022 3:15pm

hey dehydratech

WHEN are "your drs" gping to buy lex? $6? $5? $4? $3? $2???? damn they must own it all by now or your full of chit for everyone else, who has been had, AGAIN. DO NOT LISTEN TO ...more

179

Discussion

Post by WakeUPPon Oct 28, 2022 10:37am

remember wehn i told ya

way back I siad *gazillion name* lex pumper sounded a LOT like bid.combullish did 20+ years ago and bid.com went to zero (from 30 ish (dollars), and bid.combullish was never seen again Now WHERE is ...more

138

Comment by WakeUPPon Sep 28, 2022 9:16am

RE:Lexaria Bioscience: the $28 Billion Hypertension Market

here is the single thing to take from that "PCG may be compensated by respective clients for publicizing information relating to its client's securities. See www.pcgadvisory.com ...more

104

Discussion

Post by ranmanon Sep 20, 2022 9:09am

Lexaria Bioscience: the $28 Billion Hypertension Market

Lexaria Bioscience: Taking Aim at the $28 Billion Hypertension Market; Human Clinical Study Yields 'Remarkable' Results 2022-09-20 08:32 ET - News Release New York, New ...more

184

Discussion

Comment by ranmanon Sep 19, 2022 10:52am

RE:HEY RANMAN

Welcome back. I spent a week in PEI golfing in June. Nice place. We're going to be wealthy soon enough with LEXX. Very bullish..... whenever the general markets settle.

Discussion

Post by WakeUPPon Sep 19, 2022 10:18am

HEY RANMAN

iM baaaaaaaaaaaaaaaaaaack PEI WAS SWEET! looks like lex has gone...nowhere :( But, agpumper is stil a pumpin. dumbass SILL doesnt know the difference between an ANAYLIST and an ADVERTISEMENT duh ...more

121

Discussion

(0)
•••

Post by PressReleaseon Sep 02, 2022 9:16am

New Press Release - Lexaria Welcomes Dr. Catherine Turkel to its Board of Directors

(TheNewswire)Kelowna, British Columbia – TheNewswire - September 2, 2022 – Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce that Catherine Turkel, PharmD, PhD has joined the board of directors...read article.

(0)
•••

Post by PressReleaseon Aug 31, 2022 9:06am

New Press Release - Lexaria Receives New Patent in Mexico

(TheNewswire)Kelowna, British Columbia – TheNewswire - August 31, 2022 – Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce its continued accumulation of international patent recognition with the...read article.

Post by lscfaon Aug 15, 2022 2:11pm

$6 million financing

On August 12, 2022, Lexaria Bioscience Corp. (the “Company”) entered into an equity distribution agreement (the “Agreement”) with Maxim Group LLC (the “Distribution Agent”) under which the Company may ...more

180

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Bullboard (NDAQ:LEXX)

fins on sedar

New Press Release - Lexaria Bioscience Turns Focus to Dementia and Diabetes with New Studies

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

hey dehydratech

dehydraetech

RE:hey dehydratech

hey dehydratech

remember wehn i told ya

RE:Lexaria Bioscience: the $28 Billion Hypertension Market

Lexaria Bioscience: the $28 Billion Hypertension Market

RE:HEY RANMAN

HEY RANMAN

New Press Release - Lexaria Welcomes Dr. Catherine Turkel to its Board of Directors

New Press Release - Lexaria Receives New Patent in Mexico

$6 million financing

Featured News Links

Meet the Top 5 Best Online Brokerages in Canada

New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?

Major Funding Secured! Company Closes First Round of Private Placement

Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.

Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023

Gold, growth and sustainability in focus for this resource company

Star Diamond Corporation Announces Third Quarter 2024 Results

This $10M Deal Could Reshape the Future of Global Creator Platforms

Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits

Explained: The Psychology of Options Trading with Practical Tips

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (NDAQ:LEXX)

Featured News Links